GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ALL Adult Consortium Trial: Adult ALL Trial
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1